Article
Fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae: contributions of type II topoisomerase mutations and efflux to levels of resistance.
Antimicrobial agents and chemotherapy - 1 Nov 2000
Bast D J, Low D E, Duncan C L, Kilburn L, Mandell L A, Davidson R J, de Azavedo J C
Abstract excerpt
We report on amino acid substitutions in the quinolone resistance-determining region of type II topisomerases and the prevalence of reserpine-inhibited efflux for 70 clinical isolates of S. pneumoniae for which the ciprofloxacin MIC is >/=4 microgram/ml and 28 isolates for which the ciprofloxacin MIC is </=2 microgram/ml. The amino acid substitutions in ParC conferring low-level resistance (MICs, 4 to 8...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
